Stay updated on Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T15:55:24.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T09:42:24.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-30T04:38:42.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-23T01:55:42.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:01:01.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The webpage has undergone significant content changes, including the removal of detailed information about a Phase 2 study on nivolumab and daratumumab for relapsed/refractory multiple myeloma, while adding references to myeloma and a new revision number.
    Difference
    49%
    Check dated 2025-04-16T16:44:12.000Z thumbnail image

Stay in the know with updates to Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial page.